Total Payments
$106,438
2024 Payments
$68,329
Companies
41
Transactions
348
Medicare Patients
1,915
Medicare Billing
$184,657
Payment Breakdown by Category
Other$88,775 (83.4%)
Consulting$7,625 (7.2%)
Food & Beverage$6,820 (6.4%)
Travel$3,218 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,775 | 36 | 83.4% |
| Consulting Fee | $7,625 | 3 | 7.2% |
| Food and Beverage | $6,820 | 293 | 6.4% |
| Travel and Lodging | $3,218 | 12 | 3.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$106,438
344 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $67,091 | 43 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $28,003 | 39 | $0 (2023) |
| Allergan, Inc. | $5,524 | 17 | $0 (2020) |
| ABBVIE INC. | $1,935 | 121 | $0 (2024) |
| Boston Scientific Corporation | $1,039 | 9 | $0 (2019) |
| Covidien LP | $369.76 | 6 | $0 (2020) |
| Celgene Corporation | $347.68 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $190.35 | 9 | $0 (2024) |
| AnX Robotica Corp | $182.10 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $172.06 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,329 | 100 | AIMMUNE THERAPEUTICS, INC. ($67,091) |
| 2023 | $11,608 | 65 | NESTLE HEALTHCARE NUTRITION INC. ($10,713) |
| 2022 | $3,722 | 37 | Nestle HealthCare Nutrition Inc. ($3,085) |
| 2021 | $14,754 | 42 | Nestle HealthCare Nutrition Inc. ($14,205) |
| 2020 | $2,715 | 10 | Allergan, Inc. ($2,613) |
| 2019 | $4,299 | 42 | Allergan Inc. ($2,884) |
| 2018 | $606.49 | 30 | AbbVie, Inc. ($192.29) |
| 2017 | $404.59 | 22 | AbbVie, Inc. ($177.25) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Gastrointestinal AI | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $97.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/14/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/05/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 410 | 419 | $249,408 | $38,228 |
| 2022 | 10 | 410 | 429 | $254,935 | $39,300 |
| 2021 | 11 | 466 | 513 | $280,426 | $43,082 |
| 2020 | 17 | 629 | 703 | $361,756 | $64,047 |
Total Patients
1,915
Total Services
2,064
Medicare Billing
$184,657
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 107 | $23,219 | $8,980 | 38.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 77 | 77 | $65,219 | $8,359 | 12.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 36 | $38,412 | $6,854 | 17.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 120 | 120 | $81,600 | $5,558 | 6.8% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 21 | 21 | $17,325 | $2,789 | 16.1% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $14,325 | $2,217 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,312 | $1,772 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $3,996 | $1,698 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 113 | $24,521 | $9,738 | 39.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 67 | 67 | $56,749 | $7,310 | 12.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 107 | 107 | $70,410 | $5,646 | 8.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $30,943 | $5,212 | 16.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $19,100 | $3,456 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,632 | $2,783 | 32.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 16 | 18 | $27,666 | $2,030 | 7.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 12 | 12 | $9,336 | $2,027 | 21.7% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 17 | 17 | $4,658 | $747.79 | 16.1% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2022 | 14 | 20 | $2,920 | $350.43 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 144 | $30,555 | $11,883 | 38.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 64 | 64 | $67,634 | $6,902 | 10.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 34 | 34 | $41,822 | $6,257 | 15.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 110 | 115 | $84,138 | $4,704 | 5.6% |
| 43237 | Ultrasound examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 30 | 30 | $18,462 | $4,204 | 22.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,404 | $2,833 | 33.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $4,680 | $2,027 | 43.3% |
About Dr. Stuart Akerman, M.D
Dr. Stuart Akerman, M.D is a Gastroenterology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1154652923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Akerman, M.D has received a total of $106,438 in payments from pharmaceutical and medical device companies, with $68,329 received in 2024. These payments were reported across 348 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,775).
As a Medicare-enrolled provider, Akerman has provided services to 1,915 Medicare beneficiaries, totaling 2,064 services with total Medicare billing of $184,657. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Plano, TX
- Active Since 01/19/2010
- Last Updated 04/18/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1154652923
Products in Payments
- ZENPEP (Drug) $100,528
- AXIOS (Device) $774.91
- RINVOQ (Biological) $438.13
- SKYRIZI (Biological) $367.23
- Beacon (Device) $357.02
- ZEPOSIA (Drug) $347.68
- Humira (Biological) $344.00
- HUMIRA (Biological) $269.35
- LINZESS (Drug) $265.46
- GENERAL BILIARY DEVICES (Device) $124.25
- CLENPIQ (Drug) $121.58
- Creon (Drug) $119.83
- XIFAXAN (Drug) $115.57
- STELARA (Biological) $109.07
- VIBERZI (Drug) $108.86
- Vemlidy (Drug) $100.67
- SPYGLASS (Device) $99.62
- CONFIRM RX (Device) $95.48
- XELJANZ (Drug) $88.55
- ENTYVIO (Biological) $86.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Plano
Dr. Brian Cooley, M.d, M.D
Gastroenterology — Payments: $366,429
Gastroenterology $366,429
Dr. Son Do, M.d, M.D
Gastroenterology — Payments: $185,596
Gastroenterology $185,596
Dr. Candice Jantz, Md, MD
Gastroenterology — Payments: $19,514
Gastroenterology $19,514
Dr. Sindhu Abraham, M.d, M.D
Gastroenterology — Payments: $17,637
Gastroenterology $17,637
Dr. Adnan Badr, M.d, M.D
Gastroenterology — Payments: $16,659
Gastroenterology $16,659
Dr. Matthew Eidem, Md, MD
Gastroenterology — Payments: $16,203
Gastroenterology $16,203